Objectives To provide an early risk assessment of extending screening intervals beyond five
years for a human papillomavirus (HPV) based cervical screening programme in the …

Objective To obtain large scale and generalisable data on the long term predictive value of
cytology and human papillomavirus (HPV) testing for development of cervical intraepithelial …

Objectives To provide updated evidence about the risk of cervical intraepithelial neoplasia
grade 3 or higher (CIN3+) and cervical cancer after a negative human papillomavirus (HPV) …

Objective To compare the detection rates of precancerous and cancerous cervical lesions by
human papillomavirus (HPV) DNA testing and by conventional cytology screening. Design …

Objectives To assess whether the increased sensitivity of screening for human
papillomavirus (HPV) may represent overdiagnosis and to compare the long term duration of …

Objective To review the first two years of the primary human papillomavirus (HPV) cervical
screening programme in an HPV vaccinated population. Design Observational study …

Background Randomised controlled trials showed human papillomavirus (HPV)-based
screening leads to a significant reduction in cervical cancer incidence compared with …

We evaluated compliance with human papillomavirus (HPV) testing and risk‐adapted
patient pathways and monitored changes in high‐grade cervical disease during long‐term …

Introduction Human papillomavirus (HPV) testing as the primary cervical cancer screening
method is implemented in several countries. We report data from the first round of a large …

Objective To provide the first report on the main outcomes from the prevalence and
incidence rounds of a large pilot of routine primary high risk human papillomavirus (hrHPV) …